Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Erythropoiesis01:14

Erythropoiesis

6.4K
Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
6.4K
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

2.6K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.6K
Disorders of Leukocytes01:27

Disorders of Leukocytes

2.3K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.3K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

4.1K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.1K
Lineage Commitment01:21

Lineage Commitment

4.5K
Commitment is the  process whereby stem cells:
4.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

p53 Immunohistochemistry Is a Reliable Method for Assessing TP53 Allelic and Functional Status in TP53-Mutated Cases.

American journal of hematology·2026
Same author

The WHO Classification of Genetic Tumour Syndromes: Considerations for Genetics.

Clinical genetics·2026
Same author

Clinicopathologic features of systemic ALK-negative anaplastic large cell lymphoma with TP53 deletion.

American journal of clinical pathology·2026
Same author

Practical approaches to the diagnosis and differential diagnosis of T-lymphoblastic leukemia/lymphoma.

Human pathology·2026
Same author

Genetic Profile, Treatment Response, and Outcomes of BCR::ABL1-Positive Mixed-Phenotype Acute Leukemia: A Study From the BCR::ABL1 Pathology Group.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Same author

World Health Organization classification of tumours of the breast 6th edition 2026.

Histopathology·2026

Related Experiment Video

Updated: Mar 9, 2026

Lentiviral-mediated Knockdown During Ex Vivo Erythropoiesis of Human Hematopoietic Stem Cells
14:22

Lentiviral-mediated Knockdown During Ex Vivo Erythropoiesis of Human Hematopoietic Stem Cells

Published on: July 16, 2011

13.8K

Pure erythroid leukemia.

Wei Wang1, Sa A Wang1, L Jeffrey Medeiros1

  • 1Departments of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

American Journal of Hematology
|December 23, 2016
PubMed
Summary

The 2016 World Health Organization classification revised acute erythroid leukemia, now solely recognizing pure erythroid leukemia (PEL) as a distinct entity. This review details PEL

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • The 2016 World Health Organization (WHO) classification revised acute erythroid leukemia (AEL) categories.
  • Previously, AEL included erythroleukemia and pure erythroid leukemia (PEL).
  • In the 2016 update, erythroleukemia was merged into myelodysplastic syndromes, establishing PEL as the sole AEL subtype.

Purpose of the Study:

  • To review the clinicopathologic features, diagnosis, and molecular biology of pure erythroid leukemia (PEL).
  • To discuss the pathogenesis and novel concepts in PEL.
  • To provide an overview of future research directions for PEL.

Main Methods:

  • Literature review of clinicopathologic, diagnostic, and molecular data on PEL.
  • Analysis of recent updates in WHO classification of myeloid neoplasms.

More Related Videos

Direct Lineage Reprogramming of Adult Mouse Fibroblast to Erythroid Progenitors
11:46

Direct Lineage Reprogramming of Adult Mouse Fibroblast to Erythroid Progenitors

Published on: December 14, 2018

6.9K
Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.9K

Related Experiment Videos

Last Updated: Mar 9, 2026

Lentiviral-mediated Knockdown During Ex Vivo Erythropoiesis of Human Hematopoietic Stem Cells
14:22

Lentiviral-mediated Knockdown During Ex Vivo Erythropoiesis of Human Hematopoietic Stem Cells

Published on: July 16, 2011

13.8K
Direct Lineage Reprogramming of Adult Mouse Fibroblast to Erythroid Progenitors
11:46

Direct Lineage Reprogramming of Adult Mouse Fibroblast to Erythroid Progenitors

Published on: December 14, 2018

6.9K
Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.9K
  • Synthesis of current understanding and future perspectives on PEL.

    • Main Results:

    • Pure erythroid leukemia (PEL) is now the only recognized subtype of acute erythroid leukemia.
    • PEL is a rare, aggressive leukemia with poorly characterized biology.
    • The review consolidates existing knowledge and highlights research gaps.

    Conclusions:

    • The 2016 WHO classification refined the diagnosis of acute erythroid leukemia, focusing on PEL.
    • Further research into PEL's biology, pathogenesis, and molecular characteristics is crucial.
    • Understanding PEL is essential for developing targeted therapies and improving patient outcomes.